Skip to content
Screener

Globus Medical GMED Net Change in Cash

Net Change in Cash at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Stryker logo
StrykerSYK
$513M
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$35.76M+241%
Boston Scientific logo
Boston ScientificBSX
-$504M-261%
IAR
Integra LifeSciencesIART
-$22.39M-5.7%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$14.2M

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$10.93B+52.9%
Enterprise value$10.54B+49.6%
P/E20.4×+0.4×
P/S3.5×+0.8×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(In thousands)Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Repayment of senior convertible notes(449,985)
Net cash provided by/(used in) financing activities(116,299)(660,333)
Effect of foreign exchange rates on cash(2,495)17,899
Net increase/(decrease) in cash and cash equivalents(18,411)(554,992)
Cash and cash equivalents at beginning of period526,156784,438
Cash and cash equivalents at end of period$507,745$229,446
Supplemental disclosures of cash flow information:
Income taxes paid, net$30,603$93,226

Item 1. Financial Statements

FAQ

What is Globus Medical's net change in cash?
Globus Medical (GMED) reported net change in cash of -$53.21M in Q2 2026.
How has Globus Medical's net change in cash changed year-over-year?
Globus Medical's net change in cash increased by 77.0% year-over-year, from -$231.82M to -$53.21M.
What is the long-term trend for Globus Medical's net change in cash?
Over 2 years (2021 to 2024), Globus Medical's net change in cash has grown at a 161.6% compound annual growth rate (CAGR), from -$46.33M to $317.15M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Globus Medical's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude